Vericel Stock News

MetLife Investment Management LLC trimmed its position in Vericel Co. (NASDAQ:VCEL) by 10.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 16,730 shares of the biotechnology companys stock after selling 1,902 shares during the quarter. MetLife Investment Management LLCs holdings in Vericel were []

Hanseatic Management Services Inc. raised its position in Vericel Co. (NASDAQ:VCEL) by 9.4% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 13,721 shares of the biotechnology companys stock after acquiring an additional 1,175 shares during the period. Vericel makes up 1.2% of Hanseatic Management Services Inc.s investment []

Vericel Co. (NASDAQ:VCEL) Truist Securiti decreased their FY2021 earnings per share estimates for Vericel in a report released on Tuesday, November 9th. Truist Securiti analyst S. Brodovsky now expects that the biotechnology company will post earnings of ($0.09) per share for the year, down from their previous estimate of $0.08. Truist Securiti also issued []

CAMBRIDGE, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Co

Vericel Corporation (VCEL) CEO Nick Colangelo on Q3 2021 Results - Earnings Call Transcript

Vericel Corporation (VCEL) delivered earnings and revenue surprises of -266.67% and -11.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the st

Vericel (NASDAQ:VCEL) reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM. Here's what investors need to know about the announcement.

CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the followin

Hint: it doesn't really matter what kind of market it is.

CAMBRIDGE, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, announced the appointment o

Vericel Corporation (VCEL) CEO Nick Colangelo on Q2 2021 Results - Earnings Call Transcript

Vericel Corporation (VCEL) delivered earnings and revenue surprises of -33.33% and 7.04%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

CAMBRIDGE, Mass., July 21, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the followin

Restoring cartilage in sports medicine and rebuilding skin after severe burns gave this small-cap big upside

NEW YORK, July 18, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Vericel Corporation ("Vericel" or the "Company") (NASDAQ: VCEL).  Such investors are advised